The largest database of trusted experimental protocols

16 protocols using t75 flasks

1

HNSCC and HDF Cell Culture Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
A HNSCC cell line (SCC-9) was purchased from American Type Culture Collection (ATCC) (CRL-1629; Manassas, VA, USA). The cells used in this study were transformed cells and, thus, review board approval was not required. HDFs were acquired from Lonza (CC-2509; Basel, Switzerland). Cell passage numbers used were between 3 and 12. HDF cells were cultured in DMEM supplemented with 10% (v/v) FBS and a 1% (v/v) antibiotic–antimycotic solution. HNSCC cells were cultured in 1:1 DMEM:F-12 supplemented with 10% (v/v) FBS, 1% (v/v) antibiotic–antimycotic solution, and 400 ng/mL of hydrocortisone. Each cell line was cultured in T75 flasks from Sigma-Aldrich and incubated at 37°C in a humidified atmosphere of 95% air and 5% carbon dioxide.
+ Open protocol
+ Expand
2

BV2 Microglia Cell Line Culture and Stimulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The BV2 microglia cell line CVCL_0182 was initially obtained from Dr. Markus Kipp (formerly RWTH Aachen University, Germany; now University of Rostock, Germany), who obtained the cells from Interlab Cell Line Collection (ICLC), Italy (accession number: ICLC ATL03001; http://wwwsql.iclc.it/det_list.php). The BV2 cell line was cultured in RPMI1640 (Roswell Park Memorial Institute 1640) GlutaMAX medium containing 10% FCS, 1% penicillin/streptomycin (P/S), and maintained in poly-l-ornithine (0.01%)-coated T75 flasks (Sigma Aldrich, Taufkirchen, Germany) in a humidified incubator at 5% CO2 and 37 °C. Cells were split every 2–3 days until passage 20. For inflammatory stimulation experiments, BV2 cells were stimulated with 20 ng/mL or 100 ng/mL mouse TNF-α (product # 300-01A, Peprotech, Hamburg, Germany) as indicated. For CSN5 mimicry or inhibition experiments, cells were pre-treated with 500 nM MLN4924 and 1 or 4 μM CSN5i-3, respectively, for 2–4 h in all experiments. Final DMSO concentrations in the vehicle groups were between 0.1% and 0.4% and did not interfere with cell viability as verified in scouting experiments.
+ Open protocol
+ Expand
3

Thawing and Maintaining Glioblastoma Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Frozen U87-EGFRvIII-Luc glioblastoma cells45 (link) overexpressing EGFRvIII, as well as the luciferase gene, were thawed and maintained in RPMI media containing 10% FBS and 1% penicillin/streptomycin (Gibco) in T75 flasks (Sigma).
+ Open protocol
+ Expand
4

Culturing Human Mesenchymal Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human mesenchymal stem cells from the bone marrow (MSC) of a 30-year-old female donor were purchased from PromoCell (Heidelberg, Germany) and cultured in MSC growth medium 2 (MSC-GM2, PromoCell), with supplement mix (PromoCell) and 1% penicillin/streptomycin. Cells were seeded at a density of 5000/cm2 in T75 flasks (Corning Costar, Sigma Aldrich, St. Louis, MO, USA), at 37 °C in a humidified atmosphere with 5% CO2. The culture medium was changed every two days and cells were trypsinized when almost 80% confluent.
+ Open protocol
+ Expand
5

TMZ Resistance in U251 Glioma Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The U251 cells were purchased from the State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai, China. The cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum in a humidified incubator (Sanyo, Osaka, Japan) with 5% CO2 at 37℃. Basal cell culture was maintained in T-75 flasks (Sigma-Aldrich, St. Louis, MO, USA). Cells were trypsinized when they reached 80-90% confluence and were seeded into 6-well plates. TMZ was added to the 6-well plates at an initial concentration of 0.25 µg/mL. The concentration was doubled after the cells were cultured for 15 days, and the final concentration of TMZ was 16 µg/mL. After withdrawal of TMZ for 2 months, the cells were re-challenged with 16 µg/mL TMZ for 1 week every month.
+ Open protocol
+ Expand
6

Murine ESC-D3 Pluripotency Maintenance

Check if the same lab product or an alternative is used in the 5 most similar protocols
Murine ESC-D3 (ATCC, Manassas, VA) were cultured on 0.1% gelatin (Sigma, St. Louis, MO) coated T-75 flasks (Sigma, St. Louis, MO) in high glucose Dulbecco’s Modified Eagle Medium (DMEM, Invitrogen, Carlsbad, CA) supplemented with 15% fetal bovine serum (FBS, Invitrogen, Carlsbad, CA), 1% non-essential amino acid (NEAA), 10,000 U/mL of penicillin and 10,000 μg/mL streptomycin, and 0.1 mM ß-Mercaptoethanol (ßME) (all Invitrogen, Carlsbad, CA). To maintain mESC pluripotency, mESCs were cultured in the presence of 1000 U/mL leukemia inhibitory factor (LIF, Chemicon, Billerica, MA) and passaged upon reaching confluence every third day. Cells were maintained in a humidified incubator with 5% CO2 at 37 °C.
+ Open protocol
+ Expand
7

Culturing Human Umbilical Vein Endothelial and THP-1 Monocytic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUVECs, primary human umbilical vein endothelial cells, obtained from a pool of donors, were purchased from Clonetics (Lonza, Switzerland) and cultured in endothelial basal medium (EBM-2, CC-3156, Lonza) supplemented with SingleQuot Bullet Kit (CC-4176, Lonza) containing 0.1% human recombinant epidermal growth factor (rh-EGF), 0.04% hydrocortisone, 0.1% vascular endothelial growth factor (VEGF), 0.4% human recombinant fibroblast growth factor (rh-FGF-B), 0.1% insulin-like growth factor-1 with the substitution of arginine for glutamic acid at position 3 (R3- IGF-1), 0.1% ascorbic acid, 0.1% heparin, 0.1% gentamicin and amphotericin-B (GA-1000), and 2% fetal bovine serum (FBS). The cells were seeded at a density of 5000/cm2 in T75 flasks (Corning Costar, Sigma Aldrich, St. Louis MO, USA).
Human monocytic THP-1 cells were purchased from ATCC (Rockville, MD, USA) and maintained in RPMI-1640 medium supplemented with 2-mercaptoethanol to a final concentration of 0.05 mM and with 10% heat-inactivated fetal bovine serum, 1% penicillin/streptomycin, and 1% L-glutamine (all from Euroclone, Milano, Italy). The cells were seeded at a density of 2 × 105 cells/ml in T75 flasks.
+ Open protocol
+ Expand
8

H9C2 Cell Culture Methodology

Check if the same lab product or an alternative is used in the 5 most similar protocols
H9C2 cells (rat embryonic ventricular myocytes) were obtained from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China) and were routinely cultured in complete DMEM media containing 5 mM glucose and L-glutamine (Gibco Laboratories, USA) and supplemented with 10% fetal bovine serum (Gibco Laboratories, USA) and 1% antibiotics (100 U/mL penicillin and 100 mg/mL streptomycin (Gibco Laboratories, USA)). The cell lines were cultured in T75 flasks (Sigma) at 37°C in a humidified atmosphere, with 5% CO2. Media were replaced every 2 to 3 days and cells were split when they approximately reach 80% confluence. H9C2 in logarithmic growth phase were trypsinized and seeded in 6- or 96-well plates (Sigma) for follow-up experiments.
+ Open protocol
+ Expand
9

Isolation and Expansion of Mesenchymal Stromal Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
MSCs were obtained from the marrow of two different living donors (Lonza, Walkersvile, MD) and from a cadaveric donor. Living donor BM was either directly cultured or was first processed using a ficoll gradient-density sedimentation to obtain a mononuclear fraction (MNC) before plating. Organ donor marrow was obtained as previously described (20 (link)) and was subjected to a ficoll gradient-density sedimentation to obtain MNCs that were stored in frozen aliquots that were thawed and then plated.
Whole BM or MNCs were inoculated into T-75 flasks (Corning Costar, Sigma Aldrich, St. Louis, MO) containing basal medium supplemented with 10% FBS, 10% PL-S, or 10% PL-P. In cultures supplemented with PL-P, 2 IU/mL of heparin (APP Pharmaceutical, Schaumburg, IL) was added to preclude clot formation. After 48 hours of incubation, non-adherent cells were removed, fresh medium was added and the medium was changed every 3–4 days until cells reached 80–90% confluence. Cells were detached with 0.25% trypsin (HyClone, Logan, UT), re-seeded and expanded for two more passages (P1 and P2). At each passage, cell counts and viabilities were performed. P2 cells were analyzed for MSC cell surface markers per ISCT guidelines (21 (link)) and were frozen in aliquots of 5 × 106 MSC for gene expression analysis.
+ Open protocol
+ Expand
10

Characterization of Head and Neck Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Two head and neck cancer cell lines were use in this study. Both were purchased through Merck Millipore (Darmstadt Germany).
A. UM-SCC-1 was isolated from a recurrent squamous cell carcinoma in the mouth floor of a 73-year-old male. The cell line originated from the laboratory of Dr. Thomas Carey at the University of Michigan and is negative for the Human Papilloma Virus (HPV).
B. UM-SCC-47 is also a squamous cell carcinoma but derived from a primary tumour of the lateral tongue. This cell line also originated from the laboratory of Dr. Thomas Carey at the University of Michigan and is HPV positive for HPV type 16. Oncogenicity is conferred through the expression of viral oncoproteins E6 and E7 [35 (link)].
Cell lines were cultured in T75 flasks (Sigma-Aldrich® Darmstadt DE) as a monolayer using RPMI 1640 medium (Sigma-Aldrich® Darmstadt DE) supplemented with 10% foetal calf serum (FCS), 10 mM HEPES, 12.5 μg/ml penicillin and 16 μg/ml gentamycin. Cell flasks were incubated in a humidified atmosphere at 37°C containing 5% CO2 and passaged after reaching exponential growth prior to confluency. Both cell lines were tested for the presence of mycoplasma (biotool.com B3903, Madrid ES) and found to be negative.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!